J. Mark Farrant

2.5k citations

18 papers · 1.7k indexed · 1 hit paper · h-index 13

Surgery top 5%
Epidemiology top 5%
Genetics top 2%
Hepatology top 1%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Simon Travis D P Jewell M G W Kettlewell Christopher J. Ricketts Daniel J. Nolan Bernard Portmann Roger Williams Karen M. Hayllar
Topics: Liver Diseases and Immunity (6 papers)Esophageal and GI Pathology (4 papers)Gallbladder and Bile Duct Disorders (4 papers)
Cited by: Hepatology Genetics Epidemiology
Journals: The Lancet Gastroenterology PLoS ONE
Partner nations: United Kingdom United States Australia

In The Last Decade

J. Mark Farrant

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting outcome in severe ulcerative colitis.

1996 539 citations Simon Travis, J. Mark Farrant et al. Gut profile →

Peers

Countries citing papers authored by J. Mark Farrant

Since Specialization

Citations

This map shows the geographic impact of J. Mark Farrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Farrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Farrant more than expected).

Fields of papers citing papers by J. Mark Farrant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Farrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Farrant. The network helps show where J. Mark Farrant may publish in the future.

Co-authorship network of co-authors of J. Mark Farrant

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Farrant. A scholar is included among the top collaborators of J. Mark Farrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Farrant. J. Mark Farrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium 2016 ·Differentiation ·(unknown),Zoë D. Burke,(unknown),Yu Chen,Weiyuan Yu,Ramiro Jover,Michael Bock,Leigh Biddlestone,(unknown),Stephen G. Ward,J. Mark Farrant,Jonathan Slack,David Tosh	21
2	PTU-027 Prophylaxis of Post ERCP Pancreatitis in the UK. have the Esge Created Consensus? 2013 ·Gut ·Amitasha Sinha,(unknown),J. Mark Farrant,(unknown),Ben Colleypriest	1
3	Barrett's esophagus: cancer and molecular biology 2013 ·Annals of the New York Academy of Sciences ·Michael K. Gibson,(unknown),Nicholas J. Clemons,Wayne A. Phillips,Katerina Dvorak,Daniel Tong,Simon Law,(unknown),Jari Räsänen,Mark J. Krasna,Kaushal Parikh,Kausilia K. Krishnadath,Yu Chen,(unknown),(unknown),J. Mark Farrant,David Tosh,Kiron M. Das,Manisha Bajpai	21
4	Hepatocyte nuclear factor 4 (HNF4 ) provokes intestinal genes in squamous oesophageal cells 2011 ·Gut ·(unknown),J. Mark Farrant,John M. Slack,David Tosh	1
5	Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells 2010 ·PLoS ONE ·(unknown),Zoë D. Burke,Daniel Eberhard,(unknown),Chia‐Ning Shen,Anil K. Rustgi,Hiroshi Sakaue,J. Mark Farrant,David Tosh	26
6	The role of Cdx2 in Barrett's metaplasia 2010 ·Biochemical Society Transactions ·(unknown),J. Mark Farrant,Jonathan Slack,David Tosh	13
7	Advanced imaging in rheumatoid arthritis 2006 ·Skeletal Radiology ·J. Mark Farrant,Philip O’Connor,Andrew J. Grainger	46
8	Definition of primary sclerosing cholangitis 1999 ·Journal of Hepato-Biliary-Pancreatic Surgery ·J. Mark Farrant	1
9	Pigbel-like syndrome in a vegetarian in Oxford. 1996 ·Gut ·J. Mark Farrant,Zoë Traill,Christopher P. Conlon,B L Warren,N. J. Mortensen,Fergus Gleeson,D P Jewell	14
10	Predicting outcome in severe ulcerative colitis.breakdown → 1996 ·Gut ·Simon Travis,J. Mark Farrant,Christopher J. Ricketts,Daniel J. Nolan,(unknown),M G W Kettlewell,D P Jewell	539
11	Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease 1996 ·The Lancet ·(unknown),J. Mark Farrant,(unknown),J I Bell,(unknown),Michael Bunce,Cécile Julier	268
12	Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis 1995 ·Gastroenterology ·John Ramage,Anthony J. Donaghy,J. Mark Farrant,(unknown),Roger Williams	197
13	Natural history and prognostic variables in primary sclerosing cholangitis 1991 ·Gastroenterology ·J. Mark Farrant,Karen M. Hayllar,Mark Wilkinson,John Karani,Bernard Portmann,David Westaby,Roger Williams	357
14	Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma 1991 ·Cancer ·(unknown),P J Johnson,J. Mark Farrant,R. Williams	89
15	Strong associations between HLA-DQA, DQB and DRB3 alleles and autoimmune chronic active hepatitis demonstrated by PCR oligonucliotide analysis 1991 ·Journal of Hepatology ·Derek G. Doherty,Peter T. Donaldson,J. Mark Farrant,James A. Underhill,(unknown),(unknown),P. J. Johnson,K. I. Welsh,A.L.W.F. Eddleston,A. P. Mowat,Randolph T. Williams	1
16	Activation of the complement system in primary sclerosing cholangitis 1989 ·Gastroenterology ·Giorgio Senaldi,(unknown),S. Magrin,J. Mark Farrant,Graeme Alexander,Diego Vergani,Roger Williams	41
17	Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome 1989 ·Clinical and Experimental Dermatology ·J. Mark Farrant,M.R. JUDGE,R. P. H. Thompson	21
18	NEPHROTIC SYNDROME IN CHRONIC LYMPHOCYTIC LEUKAEMIA 1988 ·British Journal of Haematology ·J. Mark Farrant,Colin G. Taylor,Stephen Beer	5

About J. Mark Farrant

J. Mark Farrant is a scholar working on Hepatology, Nephrology and Genetics, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (6 papers), Esophageal and GI Pathology (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). The work is most often cited by research in Hepatology (554 citations), Genetics (753 citations) and Epidemiology (816 citations). J. Mark Farrant has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Simon Travis, D P Jewell, M G W Kettlewell, Christopher J. Ricketts, Daniel J. Nolan, Bernard Portmann, Roger Williams, Karen M. Hayllar, John Karani and David Westaby. Their work appears in journals such as The Lancet, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact